Muscle Fatigability and Trip-specific Fall Risk in Adults With Knee Osteoarthritis

May 1, 2026 updated by: University of Delaware

The goal of this clinical trial is to learn about how fatigue affects the risk of falling in adults aged 55-70 years with and without knee osteoarthritis. The main questions this trial aims to answer are:

  • Does fatigue increase the risk of tripping while walking? and
  • Does fatigue increase the risk of falling in response to a trip while walking? Participants will
  • Complete questionnaires
  • Wear a device that measures physical activity for 5-7 days
  • Complete a 30 minute walk on a treadmill
  • Complete the following before and after the treadmill walk:

    • Computer test to measure mental fatigue
    • Maximal strength testing
    • Balance test

Researchers will compare adults with and without knee osteoarthritis to see if fall risk in adults with knee osteoarthritis is affected more by walking activity compared to adults without knee osteoarthritis.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Delaware
      • Newark, Delaware, United States, 19713
        • University of Delaware

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

For adults with knee osteoarthritis:

  • presence of occasional to frequent knee pain
  • knee pain that is primarily in the medial knee joint compartment
  • minimal morning joint stiffness

For all participants:

  • able to walk continuously for 30 minutes without an assistive device

Exclusion Criteria:

  • fracture or surgery within 1 year
  • history of joint replacement
  • lower-extremity joint injections within 3 months
  • history of stroke or other neurological condition
  • cardiovascular or pulmonary conditions that limit daily activity or that preclude participation in exercise
  • history of major lower extremity or back injury or pain (except for knee osteoarthritis)
  • history of lower extremity amputation
  • use an orthotic or prosthetic to walk
  • use of beta blockers or other medications that affect fatigue
  • use of medications that affect balance
  • diabetic neuropathy
  • acute illness or the presence of lesions on the torso or lower extremities
  • BMI greater than 35
  • body weight over 265 lbs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Healthy
Participants will walk on a treadmill at their preferred speed for 30 minutes. One minute "challenge" periods will occur at minutes 7, 17, and 27, when the treadmill speed will increase by 50%. This walk will induce a magnitude of muscle fatigue corresponding to an individual participant's fatigability.
Experimental: Knee osteoarthritis
Participants will walk on a treadmill at their preferred speed for 30 minutes. One minute "challenge" periods will occur at minutes 7, 17, and 27, when the treadmill speed will increase by 50%. This walk will induce a magnitude of muscle fatigue corresponding to an individual participant's fatigability.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Minimum toe clearance during walking
Time Frame: Beginning and end of 30 minute treadmill walk
Minimum toe clearance will be calculated from the first and last minutes of the treadmill walk using optical motion capture.
Beginning and end of 30 minute treadmill walk
Anterior stability margins during walking
Time Frame: Beginning and end of 30 minute treadmill walk
Anterior stability margins will be calculated from the first and last minutes of the treadmill walk using optical motion capture.
Beginning and end of 30 minute treadmill walk
Anterior reactive stepping
Time Frame: Beginning and end of 30 minute treadmill walk
Stability margins will be calculated from a lean-release test conducted before and after the 30 minute treadmill walk
Beginning and end of 30 minute treadmill walk
Knee extensor fatigability
Time Frame: Before and after the 30 minute treadmill walk
Knee extensor fatigability will be calculated as the change in maximum knee extensor power (measured via dynamometry) pre- to post-30 minute treadmill walk
Before and after the 30 minute treadmill walk

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 14, 2024

Primary Completion (Actual)

August 27, 2025

Study Completion (Actual)

August 27, 2025

Study Registration Dates

First Submitted

January 5, 2024

First Submitted That Met QC Criteria

January 18, 2024

First Posted (Actual)

January 29, 2024

Study Record Updates

Last Update Posted (Actual)

May 6, 2026

Last Update Submitted That Met QC Criteria

May 1, 2026

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis, Knee

Clinical Trials on 30 minute treadmill walk

Subscribe